We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+4.42%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$187M
AUM Growth
+$6.15M
Cap. Flow
-$1.49M
Cap. Flow %
-0.8%
Top 10 Hldgs %
61.08%
Holding
330
New
56
Increased
56
Reduced
66
Closed
23

Sector Composition

Rank Sector Weight
1 Real Estate 3.18%
2 Financials 1.39%
3 Healthcare 1.19%
4 Technology 0.67%
5 Industrials 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVW icon
51
iShares S&P 500 Growth ETF
IVW
$75.5B
$171K 0.09%
5,612
PTVCB
52
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
$169K 0.09%
6,608
ESGR
53
DELISTED
Enstar Group
ESGR
$164K 0.09%
1,000
AAPL icon
54
Apple
AAPL
$4.43T
$161K 0.09%
5,712
-1,500
-21% -$39.7K
MKL icon
55
Markel Group
MKL
$23.3B
$158K 0.08%
170
SCHZ icon
56
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
$155K 0.08%
5,760
IYE icon
57
iShares US Energy ETF
IYE
$1.74B
$150K 0.08%
3,840
HEFA icon
58
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.55B
$144K 0.08%
5,788
IHD
59
Voya Emerging Markets High Income Dividend Equity Fund
IHD
$130M
$136K 0.07%
16,627
PM icon
60
Philip Morris
PM
$292B
$136K 0.07%
1,400
-202
-13% -$20.2K
BUD icon
61
AB InBev
BUD
$166B
$131K 0.07%
1,000
MRK icon
62
Merck
MRK
$316B
$131K 0.07%
2,203
+315
+17% +$18.4K
GILD icon
63
Gilead Sciences
GILD
$163B
$127K 0.07%
1,605
+266
+20% +$21.6K
WAT icon
64
Waters Corp
WAT
$36.8B
$127K 0.07%
800
INTC icon
65
Intel
INTC
$459B
$126K 0.07%
3,346
+200
+6% +$7.08K
LH icon
66
Labcorp
LH
$24.9B
$124K 0.07%
1,048
PNC icon
67
PNC Financial Services
PNC
$100B
$119K 0.06%
1,320
-64
-5% -$5.49K
SLB icon
68
SLB Ltd
SLB
$73.2B
$114K 0.06%
1,445
+75
+5% +$5.95K
PFE icon
69
Pfizer
PFE
$143B
$113K 0.06%
3,520
IBM icon
70
IBM
IBM
$213B
$107K 0.06%
705
XOM icon
71
ExxonMobil
XOM
$643B
$106K 0.06%
1,217
-56
-4% -$4.97K
AGG icon
72
iShares Core US Aggregate Bond ETF
AGG
$137B
$104K 0.06%
921
BNY
73
Bank of New York Mellon
BNY
$106B
$100K 0.05%
2,502
+502
+25% +$20.1K
GSK icon
74
GSK
GSK
$103B
$99K 0.05%
1,843
IJT icon
75
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.37B
$97K 0.05%
1,420

Similar funds

Roble Belko & Company's Q3 2016 Portfolio in Review

As of Q3 2016, Roble Belko & Company held 330 positions worth $187M, up 3.4% from $181M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Roble Belko & Company's Q3 2016 filing shows 56 new, 56 increased, 66 reduced and 23 closed positions. Its largest new stake was Annaly Capital Management: 1,423 shares worth $60K. The largest sale was State Street SPDR S&P Dividend ETF, an estimated $2.71M.

By sector, the portfolio is most concentrated in Real Estate at 3.2% of assets, up from 3.1% a quarter earlier, followed by Financials and Healthcare.

  • Roble Belko & Company's largest Q3 2016 buy was Annaly Capital Management: 1,423 shares worth $60K.
  • Roble Belko & Company added most to Vanguard Total International Stock ETF in Q3 2016, an estimated $3.53M increase.
  • Roble Belko & Company's biggest Q3 2016 reduction was State Street SPDR S&P Dividend ETF, cutting an estimated $2.71M.
  • Roble Belko & Company fully exited ResMed in Q3 2016, selling an estimated $55K.
  • Roble Belko & Company's ten largest holdings make up 61% of its $187M portfolio in Q3 2016.
  • Roble Belko & Company opened 56 new positions and closed 23 in Q3 2016.
  • Roble Belko & Company's portfolio value rose 3.4% quarter-over-quarter to $187M.

Based on Roble Belko & Company's 13F filing for Q3 2016, filed 1 Nov 2016.